Autoimmunity BioSolutions
Houston
About Autoimmunity BioSolutions
Autoimmunity BioSolutions is working on a next-generation immuno-corrective therapy that restores normal immune function in a genetically defined subgroup of autoimmune patients, where the autoimmune pathology is driven by an SNP.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Nov 2024)
- Website: abstherapeutics.com
- Phone: [email protected]
Industries & Categories
Health Care, Therapeutics
Canonical: https://fsome.com/organization/autoimmunity-biosolutions-58271 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.